News

Harmony Biosciences Holdings, Inc. has released topline results from its Phase 3 RECONNECT Study evaluating ZYN002, a transdermal cannabidiol gel, in patients with Fragile X syndrome…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Inluriyo (imlunestrant, 200 mg tablets), a new oral treatment from Eli Lilly and Company, for adults with estrogen…
Read More...

Eli Lilly and Company announced that the European Commission has granted marketing authorization for Kisunla (donanemab) to treat adults with early symptomatic Alzheimer’s disease (AD),…
Read More...

Cellectar Biosciences, a late-stage clinical biopharmaceutical company specializing in cancer drug development, has entered into an agreement with Evestia Clinical to provide full…
Read More...

AstraZeneca and Daiichi Sankyo have announced that the U.S. Food and Drug Administration (FDA) has accepted their supplemental Biologics License Application (sBLA) for Enhertu…
Read More...

Sanofi Ventures has received an additional $625 million multi-year capital commitment from its parent company, Sanofi, increasing its total assets under management to over $1.4 billion.…
Read More...

Moderna, Inc. has officially opened its Moderna Innovation and Technology Centre (MITC) at the Harwell Science and Innovation Campus in Oxfordshire, UK. This new facility will…
Read More...

Merck and Siemens have signed a new Memorandum of Understanding (MoU) to deepen their strategic partnership aimed at accelerating digital transformation across the life science industry…
Read More...

TegMine Therapeutics, a biotech company specializing in precision oncology by targeting cancer-driving glycoproteins, has announced a strategic research and development collaboration…
Read More...

Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the company’s supplemental New Drug Application (sNDA) for…
Read More...

Roche has announced positive results from the Phase III evERA study evaluating giredestrant combined with everolimus in patients with estrogen receptor (ER)-positive, HER2-negative,…
Read More...

Moderna, Inc. has announced promising preliminary immunogenicity results for the 2025-2026 formula of its COVID-19 vaccine, mNEXSPIKE, which targets the SARS-CoV-2 LP.8.1 variant. Data…
Read More...

Eli Lilly and Company announced plans to construct a $6.5 billion state-of-the-art manufacturing facility at Generation Park in Houston, Texas. This new site will focus on producing…
Read More...

Servier, the independent international pharmaceutical group, announced that the European Commission (EC) has approved VORANIGO (vorasidenib) for treating predominantly non-enhancing…
Read More...

The U.S. Food and Drug Administration (FDA) has extended the target action date for its review of Sanofi’s new drug application (NDA) for tolebrutinib by three months, now set for…
Read More...

Minovia Therapeutics Ltd., a clinical-stage biotech focused on mitochondrial diseases and age-related conditions, has announced that the U.S. Food and Drug Administration (FDA) has…
Read More...

Novo Nordisk announced new findings from the REACH real-world study demonstrating that Ozempic (once-weekly injectable semaglutide) reduced the risk of major adverse cardiovascular…
Read More...

FUJIFILM Biotechnologies, a leading contract development and manufacturing organization (CDMO), announced a major expansion of its global partnership with immunology company argenx SE.…
Read More...

Roche announced that it has entered into a definitive agreement to acquire 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company developing innovative therapies for…
Read More...

Biogen Inc. announced that the European Commission (EC) has granted marketing authorization for ZURZUVAE (zuranolone) as a treatment for postpartum depression (PPD) in adults following…
Read More...